ISSN: 2332-0877

感染症と治療ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Japanese Encephalitis and its Epidemiology

Malhotra S, Sharma S, Kumar P and Hans C

Japanese encephalitis (JE) is among the most common cause of viral encephalitis in human beings and is found worldwide. JE, a zoonotic disease, is caused by JE virus (JEV), a mosquito-borne flavivirus and belongs to the family Flaviviridae. About 1% of human JEV infections result in JE, but 20–30% of these cases are fatal and 30-50% of survivors have significant neurologic or psychiatric sequelae. WHO estimated that approximately 67 900 JE cases occur annually in the 24 JE-endemic countries with an overall incidence of 1.8 per 100 000 population and 75% of these cases occur in children aged 0-14 years, which gives an estimated overall annual incidence of 5.4 per 100 000 in this age group. Five genotypes of JEV (1 to 5), based on structural protein sequences, with geographically distinct distributions, have been described. Diagnosis of JE can be made by virus isolation in cell/ tissue culture, antigen detection, and antibody detection. There is no specific treatment of JE, and only supportive care is provided to patient thus prevention of JE is considered as an important intervention in JE. Hence a strong surveillance system along with implementation of high quality vaccination program for children is the key ingredients to reduce the number of JE cases in endemic areas.